MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.230
+0.020 (1.65%)
At close: Jan 21, 2026, 4:00 PM EST
1.220
-0.010 (-0.81%)
After-hours: Jan 21, 2026, 4:11 PM EST
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $131.21 million as of January 21, 2026. Its market cap has decreased by -70.09% in one year.
Market Cap
131.21M
Enterprise Value
41.51M
1-Year Change
-70.09%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $131.21M, a decrease of -73.48%. That is a compound annual growth rate of -23.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 129.08M | -21.94% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inogen | 168.59M |
| Lucid Diagnostics | 166.60M |
| Treace Medical Concepts | 165.35M |
| Apyx Medical | 159.19M |
| CVRx, Inc. | 146.51M |
| LENSAR | 143.33M |
| Picard Medical | 137.82M |
| Sera Prognostics | 135.08M |